Literature DB >> 1578471

Acute colchicine intoxication--possible role of erythromycin administration.

Y Caraco1, C Putterman, R Rahamimov, E Ben-Chetrit.   

Abstract

A 29-year-old patient with familial Mediterranean fever and amyloidosis involving the kidney, liver, and gastrointestinal tract received longterm colchicine, 1 mg daily. In the last year she developed diarrhea and abdominal pain, that coincided with toxic colchicine blood levels. After 2 weeks of oral erythromycin therapy she was hospitalized for acute, life threatening colchicine toxicity, with fever, diarrhea, abdominal pain, myalgia and lower extremity parasthesias and later convulsions and alopecia. Pancytopenia evolved into rebound leukocytosis, disturbed liver function and hypoglycemia. After a long stormy course she improved. Colchicine toxicity with combined liver and renal impairment and the role of erythromycin in her colchicine toxicity are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1578471

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  6 in total

1.  Evidence of Clinically Meaningful Drug-Drug Interaction With Concomitant Use of Colchicine and Clarithromycin.

Authors:  Lorenzo Villa Zapata; Philip D Hansten; John R Horn; Richard D Boyce; Sheila Gephart; Vignesh Subbian; Andrew Romero; Daniel C Malone
Journal:  Drug Saf       Date:  2020-07       Impact factor: 5.606

Review 2.  EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  W Zhang; M Doherty; T Bardin; E Pascual; V Barskova; P Conaghan; J Gerster; J Jacobs; B Leeb; F Lioté; G McCarthy; P Netter; G Nuki; F Perez-Ruiz; A Pignone; J Pimentão; L Punzi; E Roddy; T Uhlig; I Zimmermann-Gòrska
Journal:  Ann Rheum Dis       Date:  2006-05-17       Impact factor: 19.103

3.  Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein.

Authors:  Arik Dahan; Gordon L Amidon
Journal:  Pharm Res       Date:  2008-12-02       Impact factor: 4.200

Review 4.  Colchicine: its mechanism of action and efficacy in crystal-induced inflammation.

Authors:  George Nuki
Journal:  Curr Rheumatol Rep       Date:  2008-07       Impact factor: 4.592

5.  Severe colchicine intoxication after self-administration of colchicine concomitantly with loxoprofen.

Authors:  Akinori Yamazaki; Hiroshi Iranami; Koichi Nishikawa
Journal:  J Anesth       Date:  2012-12-08       Impact factor: 2.078

6.  Colchicine intolerance in FMF patients and primary obstacles for optimal dosing

Authors:  Hasan Satiş; Berkan Armağan; Erdal Bodakçi; Nuh Ataş; Alper Sari; Nazife Şule Yaşar Bilge; Dilek Yapar; Reyhan Bilici Salman; Gözde Kübra Yardimci; Hakan Babaoğlu; Levent Kiliç; Berna Göker; Şeminur Haznedaroğlu; Timuçin Kaşifoğlu; Umut Kalyoncu; Abdurrahman Tufan
Journal:  Turk J Med Sci       Date:  2020-08-26       Impact factor: 0.973

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.